Sector: MedicalBIOD (NASDAQ: BIOD)
Headlines
- Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009
Sep 11, 2009 07:00 AM | BIOD, MS
- Biodel (NASDAQ:BIOD): The Next Surprise FDA Approval? - Leerink
Aug 14, 2009 11:47 AM | BIOD
- Earnings Preview for Dec 8 - 12 - Earnings Preview
Dec 05, 2008 03:17 PM | ADCT, ALOG, AZO, BIOD, BLC, CIEN
- Bad News Bears - Feb 7 2008 10:41AM
Feb 07, 2008 10:40 AM | AAPL, AAUK, ACGY, AKAM, AKNS, ALTR
- IPO REPORT: Solera Fattens IPO In Busy Deal Day
May 11, 2007 02:31 PM | BIOD, COWN, EVR, JMP, SLH
- IPO REPORT: Solera Fattens IPO In Busy Deal Day
May 11, 2007 02:31 PM | BIOD, COWN, EVR, JMP, SLH
- IPO REPORT: Solera Fattens IPO In Busy Deal Day
May 11, 2007 02:31 PM | BIOD, COWN, EVR, JMP, SLH
- Biodel Inc. To Present at Oppenheimer 20th Annual Healthcare Conference on November 3rd, 2009
Oct 30, 2009 07:55 AM | BIOD
- Biodel Reports Third Quarter Fiscal Year 2009 Financial Results
Aug 07, 2009 07:53 AM | BIOD
- Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009
Aug 03, 2009 07:05 AM | BIOD
- Biodel Inc. To Present at 8th Annual Needham & Company Life Sciences Conference on June 11th, 2009
Jun 09, 2009 05:01 PM | BIOD
- VIAject® Presentations at ADA Meeting Highlight Drug’s Mechanism of Absorption and Microvascular Effects
Jun 08, 2009 04:07 PM | BIOD
- Biodel Inc. Reports Second Quarter Fiscal Year 2009 Financial Results
May 07, 2009 04:13 PM | BIOD
- Biodel to Report Second Quarter Fiscal Year 2009 Results on May 7, 2009
May 04, 2009 04:29 PM | BIOD
- Biodel to Submit New Drug Application for VIAject® to FDA
Mar 24, 2009 04:01 PM | BIOD
- Biodel Reports First Quarter Fiscal Year 2009 Financial Results and Clinical Update
Feb 05, 2009 04:03 PM | BIOD
- Biodel to Report First Quarter Fiscal Year 2009 Results and Top Line Results of Bioequivalence Study on February 5, 2009
Jan 30, 2009 04:06 PM | BIOD
- Form 4 Biodel Inc For: Nov 09 Filed by: Krasner Alan Seth (10K)
Nov 12, 2009 10:38 AM
- Form 4 Biodel Inc For: Oct 21 Filed by: GREAT POINT PARTNERS LLC (10K)
Oct 23, 2009 05:46 PM
- Form 4 Biodel Inc For: Oct 19 Filed by: GREAT POINT PARTNERS LLC (10K)
Oct 21, 2009 05:44 PM
- Form 4 Biodel Inc For: Oct 19 Filed by: WEISMAN SCOTT (10K)
Oct 21, 2009 05:42 PM
- Form 4 Biodel Inc For: Oct 15 Filed by: GREAT POINT PARTNERS LLC (10K)
Oct 19, 2009 05:44 PM
- Form 4 GREAT POINT PARTNERS For: Oct 13 (10K)
Oct 15, 2009 05:52 PM
- Form 4 GREAT POINT PARTNERS For: Oct 09 (10K)
Oct 13, 2009 05:41 PM
- Form 4 GREAT POINT PARTNERS For: Oct 07 (10K)
Oct 09, 2009 05:40 PM
- Form 4 GREAT POINT PARTNERS For: Oct 05 (10K)
Oct 07, 2009 05:46 PM
- Form 4 GREAT POINT PARTNERS For: Sep 22 (10K)
Sep 24, 2009 05:39 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
BIOD
|
Compare to S&P
|
| YTD |
-13.90 %
|
-28.74 %
|
| 4 Weeks |
-12.81 %
|
-13.76 %
|
| 12 Weeks |
-17.66 %
|
-22.37 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 4.08 %
|
|
EPS Growth in Last Year: -9.30 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
